Castration-Resistant Prostate Cancer (CRPC)

15 clinical trials · Condition

Record	Firm	Date
Safety Evaluation of Autologous Dendritic Cell Anticancer Immune Cell Therapy (Cellgram-DC-PC) (NCT04615845)	Pharmicell Co., Ltd.	2021-06-21
A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Advanced Solid Tumors (MK-8628-006) (NCT02698176)	Merck Sharp & Dohme LLC	2016-05-04
A Study to Determine Enzalutamide Long-term Safety and Efficacy After Anti-androgen Therapy for CRPC (NCT02669147)	Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan	2016-01-26
A Study to Compare Capsule and Tablet Forms of MDV3100 (Enzalutamide) After Administration of a Single Set Dose Under Fasted Conditions in Healthy Male Subjects (NCT01911741)	Astellas Pharma Europe B.V.	2012-11-01
A Study to Assess the Safety of Continued Administration of MDV3100 in Subjects With Prostate Cancer Who Showed Benefit From Prior Exposure to MDV3100 (NCT01534052)	Astellas Pharma Inc	2011-10-21
Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates (NCT01911728)	Astellas Pharma Europe B.V.	2011-07-25

Every clearance here is in the API, with alerts when new ones post.